Alzheimer's Disease and Related Disorders: Treatment Approaches
Hours: 1.00
Alzheimer's disease (AD) is a progressive neurodegenerative disease that gradually worsens over time. The hallmark feature of AD is cognitive impairment such as memory loss, communication difficulties, impaired judgment, and confusion resulting in a decline in functional ability as well as behavioral and personality changes. Caring for persons with cognitive impairments is complex and multifaceted, with every person with AD having a different plan of care based on their needs, preferences, and abilities, and this plan sometimes needs to change from day to day. The goal of care for the person with AD is to help the individual maintain the functional ability for as long as possible and improve the quality of life. This course will review the different pharmacological treatments available for AD, as well as recent research on the effectiveness of the available medications, new advances into the treatment of the disease, and alternative treatments that may be used.
Alzheimer's disease (AD) is a progressive neurodegenerative disease that gradually worsens over time. The hallmark feature of AD is cognitive impairment such as memory loss, communication difficulties, impaired judgment, and confusion resulting in a decline in functional ability as well as behavioral and personality changes. Caring for persons with cognitive impairments is complex and multifaceted, with every person with AD having a different plan of care based on their needs, preferences, and abilities, and this plan sometimes needs to change from day to day. The goal of care for the person with AD is to help the individual maintain the functional ability for as long as possible and improve the quality of life. This course will review the different pharmacological treatments available for AD, as well as recent research on the effectiveness of the available medications, new advances into the treatment of the disease, and alternative treatments that may be used.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.00 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.00 Nursing Contact Hours after successfully completing this course.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
South Carolina Board of Nursing
This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Describe the mode of action, dosing considerations, precautions, and adverse reactions of medications commonly prescribed to treat AlzheimerÂ’s disease.
Identify three alternative treatments for Alzheimer’s disease.
Explain advances in Alzheimer’s disease treatment.
Indicate mental health problems frequently present in Alzheimer’s disease and the pharmacological treatment used to treat those conditions.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Pharmacologic Treatment of AD
A Quick Review
Cholinesterase Inhibitors
Dosing Considerations
Galantamine Dosing
Rivastigmine Dosing
Donepezil Dosing
Warnings and Precautions
Adverse Reactions
NMDA Receptors
Memantine Action and Dosing
Memantine Warnings and Precautions
Memantine/Donepezil
Review
Summary
Section 3: Alternative Treatments for AD
Herbal Remedies
Acupuncture and Acupressure
Aromatherapy
Yoga
Diet
Review
Summary
Section 4: Current Research and Advancements for AD
A Future Without Alzheimer's Disease
Diagnosis
Review
Summary
Section 5: Mental Health in AD
Depression in AD
Anxiety in AD
Behavior Changes
Review
Summary
Section 6: Conclusion
Summary
Course Contributor
References
Congratulations!
Kimberly Matthews, RN obtained a nursing degree from Western Kentucky University in 1998. Ms. Matthews possesses over 20 years of nursing experience with over 17 of those in the Skilled Nursing industry. Ms. Matthews has extensive experience in MDS, restorative nursing programs, and nursing management. Ms. Matthews is currently a Post Acute Care Content writer and subject matter expert for MDS. Disclosure: Kim Matthews, RN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
The target audience for this course is: Entry level Administrators; Nurses; in the following settings: Post-Acute Care.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
